Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Passes Fourth COVID-19 Spending Package, Includes $25Bn For Additional Testing, Contact Tracing

Executive Summary

A Paycheck Protection Program and Health Care Enhancement Act bill that would dole out $25bn for additional testing by federal agencies and $75bn to Medicare suppliers providing testing equipment passed the US Senate on 21 April and is headed to the House for a vote.

You may also be interested in...



US House Energy & Commerce Committee Lays Out Medtech Agenda, Membership, For 2021 Congress

The House E&C committee and its subpanels will address coronavirus testing, FDA device regulation and cybersecurity during the upcoming 117th Congress.

US Supply Of OTC COVID-19 Tests Gets Boost Through $231.8M Contract For Australian Firm

Biden administration seems to be betting Elluve's OTC at-home antigen diagnostic test will be a game changer in helping stop the spread of the coronavirus.

Biden Admin Pays Ellume $231M To Build COVID-19 US Test Plant

The government seems to be betting the company’s over-the-counter at-home antigen diagnostic test will be a game changer in stopping the spread of the coronavirus.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT126633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel